ÂÜÀòÂÒÂ×

Andrew Lee is a Senior Associate at Northpond Ventures. Andrew is a Board Director at Culture Biosciences. Previously, he was an Associate at Booz Allen Hamilton working in the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA), where he supported the development and management of a high-risk, high-reward research funding portfolio in gene editing and synthetic biology. Earlier, Andrew worked at Sangamo Biosciences (now Sangamo Therapeutics). Andrew earned a Ph.D. in microbiology and immunology from Columbia University. He received a B.A. with honors in molecular and cell biology, with an emphasis in biochemistry and molecular biology, at University of California, Berkeley.